Immix Biopharma, Inc. (IMMX)
7.48
-0.36
(-4.59%)
USD |
NASDAQ |
Nov 16, 16:00
7.49
+0.01
(+0.13%)
After-Hours: 20:00
Immix Biopharma EPS Diluted (Quarterly) : -0.188 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.188 |
| June 30, 2026 | -0.1812 |
| March 31, 2026 | -0.1822 |
| December 31, 2025 | -0.2792 |
| September 30, 2025 | -0.2376 |
| June 30, 2025 | -0.2209 |
| March 31, 2025 | -0.1529 |
| December 31, 2024 | -0.1747 |
| September 30, 2024 | -0.243 |
| June 30, 2024 | -0.1526 |
| March 31, 2024 | -0.2244 |
| December 31, 2023 | -0.2555 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.2304 |
| June 30, 2023 | -0.2378 |
| March 31, 2023 | -0.1784 |
| December 31, 2022 | -0.2872 |
| September 30, 2022 | -0.1102 |
| June 30, 2022 | -0.1126 |
| March 31, 2022 | -0.0963 |
| December 31, 2021 | -1.720 |
| September 30, 2021 | -0.0519 |
| March 31, 2021 | -0.3012 |
| September 30, 2020 | -0.015 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Arrowhead Pharmaceuticals, Inc. | -3.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.93M |
| Total Expenses (Quarterly) | 13.93M |
| Enterprise Value | 291.58M |
| Earnings Yield | -11.10% |
| Normalized Earnings Yield | -11.10 |